90 related articles for article (PubMed ID: 1658412)
1. Proposals regarding some deficiencies in the new international staging system for non-small cell lung cancer.
Watanabe Y; Shimizu J; Oda M; Hayashi Y; Iwa T; Nonomura A; Kamimura R; Takashima T
Jpn J Clin Oncol; 1991 Jun; 21(3):160-8. PubMed ID: 1658412
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
[TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification.
Christian C; Erica S; Morandi U
Lung Cancer; 2006 Nov; 54(2):185-91. PubMed ID: 16996167
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of the new TNM classification for resected lung cancer].
Miyazawa M; Shiina T; Kurai M; Makiuchi A; Numanami H; Kondo R; Takasuna K; Machida E; Hanaoka T; Yoshida K; Kaneko K; Yamanda T; Haniuda M; Amano J
Kyobu Geka; 2000 Oct; 53(11):915-8. PubMed ID: 11048441
[TBL] [Abstract][Full Text] [Related]
5. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer.
Carbone E; Asamura H; Takei H; Kondo H; Suzuki K; Miyaoka E; Tsuchiya R; Motta G
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):907-12. PubMed ID: 11689795
[TBL] [Abstract][Full Text] [Related]
6. Applicability of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers.
Suzuki M; Yoshida S; Tamura H; Wada H; Moriya Y; Hoshino H; Shibuya K; Yoshino I
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1031-6. PubMed ID: 19692261
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.
Kameyama K; Takahashi M; Ohata K; Igai H; Yamashina A; Matsuoka T; Nakagawa T; Okumura N
J Thorac Cardiovasc Surg; 2009 May; 137(5):1180-4. PubMed ID: 19379988
[TBL] [Abstract][Full Text] [Related]
8. [Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer].
Hosokawa Y; Matsuge S; Murakami Y; Satoh K; Yamazaki S; Kan T; Hatakeyama H
Kyobu Geka; 2000 Oct; 53(11):910-4. PubMed ID: 11048440
[TBL] [Abstract][Full Text] [Related]
9. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
10. Subcategorization of lung cancer based on tumor size and degree of visceral pleural invasion.
Sakakura N; Mori S; Okuda K; Fukui T; Hatooka S; Shinoda M; Matsuo K; Yatabe Y; Yokoi K; Mitsudomi T
Ann Thorac Surg; 2008 Oct; 86(4):1084-90. PubMed ID: 18805136
[TBL] [Abstract][Full Text] [Related]
11. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
[TBL] [Abstract][Full Text] [Related]
12. Results of pneumonectomy for non-small cell lung cancer: appropriateness of the new TNM staging system.
Mizushima Y; Noto H; Kusajima Y; Sugiyama S; Yamashita R; Sassa K; Kobayashi M
Oncol Rep; 1998; 5(2):437-40. PubMed ID: 9468575
[TBL] [Abstract][Full Text] [Related]
13. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
14. The revised TNM staging system for lung cancer.
Rami-Porta R; Crowley JJ; Goldstraw P
Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):4-9. PubMed ID: 19262443
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer and its operable brain metastasis: survival rate and staging problems.
Furák J; Troján I; Szöke T; Agócs L; Csekeö A; Kas J; Svastics E; Eller J; Tiszlavicz L
Ann Thorac Surg; 2005 Jan; 79(1):241-7; discussion 241-7. PubMed ID: 15620950
[TBL] [Abstract][Full Text] [Related]
16. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station.
Ichinose Y; Kato H; Koike T; Tsuchiya R; Fujisawa T; Shimizu N; Watanabe Y; Mitsudomi T; Yoshimura M; Tsuboi M;
J Thorac Cardiovasc Surg; 2001 Oct; 122(4):803-8. PubMed ID: 11581617
[TBL] [Abstract][Full Text] [Related]
17. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
Zell JA; Ou SH; Ziogas A; Anton-Culver H
Cancer; 2008 Jan; 112(1):136-43. PubMed ID: 17960795
[TBL] [Abstract][Full Text] [Related]
18. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients.
Pfannschmidt J; Muley T; Bülzebruck H; Hoffmann H; Dienemann H
Lung Cancer; 2007 Mar; 55(3):371-7. PubMed ID: 17123661
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size.
Lee PC; Korst RJ; Port JL; Kerem Y; Kansler AL; Altorki NK
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1382-9. PubMed ID: 17140961
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study.
Goya T; Asamura H; Yoshimura H; Kato H; Shimokata K; Tsuchiya R; Sohara Y; Miya T; Miyaoka E;
Lung Cancer; 2005 Nov; 50(2):227-34. PubMed ID: 16061304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]